Commissioned to celebrate 75 years of the BJC, this special issue looks back on some of the most impactful publications from the journal's long history. The original authors and leading experts giving an overview of the field and important key lessons: nature.com/bjc/volumes/128/i…
Application is now open for the BJC Reports Trainee Editorial Board. Applicants should be early career researchers (postdoctoral), or clinicians and other health professionals on an approved training scheme in a cancer-related discipline: nature.com/bjcreports/editor…
We are delighted to announce that the British Journal of Cancer has launched a new, fully open access partner journal, BJC Reports (nature.com/bjcreports).
For pre-submission enquiries and applications to the Editorial Board, please contact us at bjcreports@nature.com.
Digital Imaging: open to receiving submissions assessing:
▪️ State-of-the-art in digital imaging technology and computational output;
▪️ Radiomics;
▪️Algorithms and approaches designed to predict therapeutic response and enable “personalized medicine”
nature.com/collections/bbbja…
What's the value of negative data?
A new systematic review of Patient Attrition in Molecular Tumour Boards from our @digital_ECMT (published in @BrJCancer) shows the value of including the data that's normally left out of papers
Read it here: nature.com/articles/s41416-0…
ALT A Wordle-style grid of letters, which reads from top to bottom:
PAPER
SHOWS
WHERE
ABSENT
DATA
Then 5 blanks
The last word contains a P, E, and H, and has an S in the final position
It doesn't start with P or S, H is not the 2nd letter, P, E and S are not the 3rd letter, and E is not the 4th letter
The answer is:
HELPS
and well done if you got it!
@EdinCRC scientists report clinical and histopathological characterisation of the largest pathologically confirmed cohort of ovarian carcinosarcoma patients to date. New insights into this rare form of #ovariancancer! Published in @BrJCancer. Lay summary:
ed.ac.uk/cancer-centre/news-…
The British Journal of Cancer is seeking an exceptional candidate to serve as Editor-in-Chief of the journal, starting January 1st 2023. For further information on the role please visit: nature.com/bjc/journal-infor…. Application deadline: September 2nd 2022.
Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation
Read for free: rdcu.be/cPRNn
TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN/NF-κB signaling pathway
#OpenAccess in BJC: nature.com/articles/s41416-0…
@zhang_yaowei